143 related articles for article (PubMed ID: 9637586)
1. Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
Atkins NS; Lindo JF; Lee MG; Hanchard B; Robinson RD; Bundy DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):188-90. PubMed ID: 9637586
[No Abstract] [Full Text] [Related]
2. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.
Neva FA; Filho JO; Gam AA; Thompson R; Freitas V; Melo A; Carvalho EM
J Infect Dis; 1998 Dec; 178(6):1856-9. PubMed ID: 9815251
[TBL] [Abstract][Full Text] [Related]
5. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
7. Total serum IgE and parasite-specific IgG and IgA antibodies in human strongyloidiasis.
Rossi CL; Takahashi EE; Partel CD; Teodoro LG; da Silva LJ
Rev Inst Med Trop Sao Paulo; 1993; 35(4):361-5. PubMed ID: 8115797
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
10. Short report: long-term serum antibody isotype responses to Strongyloides stercoralis filariform antigens in eight patients treated with ivermectin.
Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
Am J Trop Med Hyg; 1996 Nov; 55(5):474-6. PubMed ID: 8940975
[TBL] [Abstract][Full Text] [Related]
11. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
12. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA
Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206
[TBL] [Abstract][Full Text] [Related]
13. Serum IgG reactivity with 41-, 31-, and 28-kDa larval proteins of Strongyloides stercoralis in individuals with strongyloidiasis.
Conway DJ; Bailey JW; Lindo JF; Robinson RD; Bundy DA; Bianco AE
J Infect Dis; 1993 Sep; 168(3):784-7. PubMed ID: 8354924
[TBL] [Abstract][Full Text] [Related]
14. Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis.
Mota-Ferreira DM; Gonçalves-Pires Mdo R; Júnior AF; Sopelete MC; Abdallah VO; Costa-Cruz JM
Acta Trop; 2009 Feb; 109(2):103-7. PubMed ID: 19007741
[TBL] [Abstract][Full Text] [Related]
15. Recombinant cDNA clones for immunodiagnosis of strongyloidiasis.
Ramachandran S; Thompson RW; Gam AA; Neva FA
J Infect Dis; 1998 Jan; 177(1):196-203. PubMed ID: 9419188
[TBL] [Abstract][Full Text] [Related]
16. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
17. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study.
Salvador F; Sulleiro E; Piron M; Sánchez-Montalvá A; Sauleda S; Molina I
Acta Trop; 2017 Dec; 176():412-414. PubMed ID: 28939495
[TBL] [Abstract][Full Text] [Related]
19. The detergent fraction is effective in the detection of IgG anti-Strongyloides stercoralis in serum samples from immunocompromised individuals.
da Silva H; de Carvalho CJ; Levenhagen MA; Costa-Cruz JM
Parasitol Int; 2014 Dec; 63(6):790-3. PubMed ID: 25091831
[TBL] [Abstract][Full Text] [Related]
20. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
